Fierce Pharma

Etcamah now joins Roche’s rival oral SERD, giredestrant, in missing [...]

Newly revealed global phase 3 data from Merck and Gilead’s [...]

Following formal sign-off from the FDA, Handa Pharmaceuticals’ branded drug [...]

Takeda’s long-time R&D chief Andy Plump will retire. Daiichi Sankyo [...]

Argonaut Manufacturing Services, a CDMO specializing in aseptic fill-finish for [...]

In his first interview after taking the reins of the [...]

Lonza’s plans for a new spray-drying facility in Bend, Oregon, [...]

With positive phase 3 results in hand, AbbVie is one [...]

In a move that at least one local HIV charity [...]

Novartis’ recent dual clinical setbacks have prompted questions from a [...]